READNA
REvolutionary Approaches and Devices for Nucleic Acid Analysis
| Coordinatore |
Organization address
address: RUE LEBLANC 25 contact info |
| Nazionalità Coordinatore | Non specificata |
| Totale costo | 15˙753˙593 € |
| EC contributo | 11˙992˙319 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2007-A |
| Funding Scheme | CP-IP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-06-01 - 2012-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address
address: RUE LEBLANC 25 contact info |
FR (PARIS 15) | coordinator | 0.00 |
| 2 |
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
Organization address
address: OLSHAUSENSTRASSE 40 contact info |
DE (KIEL) | participant | 0.00 |
| 3 |
COMPREHENSIVE BIOMARKER CENTER GMBH
Organization address
address: IM NEUENHEIMER FELD 519 contact info |
DE (HEIDELBERG) | participant | 0.00 |
| 4 |
DANMARKS TEKNISKE UNIVERSITET
Organization address
address: Anker Engelundsvej 1, Building 101A contact info |
DK (KONGENS LYNGBY) | participant | 0.00 |
| 5 |
FlexGen B.V.
Organization address
address: Wassenaarseweg 72 contact info |
NL (Leiden) | participant | 0.00 |
| 6 |
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA
Organization address
address: Baldiri i Reixac, 10-12 contact info |
ES (BARCELONA) | participant | 0.00 |
| 7 |
GENEWAVE SAS
Organization address
address: RUE PIERRE FONTAINE 4 contact info |
FR (EVRY) | participant | 0.00 |
| 8 |
GOETEBORGS UNIVERSITET
Organization address
address: VASAPARKEN contact info |
SE (GOETEBORG) | participant | 0.00 |
| 9 |
LIFE TECHNOLOGIES GmbH
Organization address
address: Frankfurter Strasse 129 B contact info |
DE (Darmstadt) | participant | 0.00 |
| 10 |
LUNDS UNIVERSITET
Organization address
address: Paradisgatan 5c contact info |
SE (LUND) | participant | 0.00 |
| 11 |
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Organization address
address: Hofgartenstrasse 8 contact info |
DE (MUENCHEN) | participant | 0.00 |
| 12 |
OLINK AB
Organization address
address: UPPSALA SCIENCE PARK contact info |
SE (UPPSALA) | participant | 0.00 |
| 13 |
OXFORD NANOPORE TECHNOLOGIES LTD
Organization address
address: ROBERT ROBINSON AVENUE - OXFORD SCIENCE PARK 4 contact info |
UK (OXFORD) | participant | 0.00 |
| 14 |
PHILIPS ELECTRONICS NEDERLAND B.V.
Organization address
address: Boschdijk 525 contact info |
NL (EINDHOVEN) | participant | 0.00 |
| 15 |
PHOTONIS FRANCE SAS
Organization address
address: AVENUE ROGER RONCIER contact info |
FR (BRIVE LA GAILLARDE) | participant | 0.00 |
| 16 |
TECHNISCHE UNIVERSITEIT DELFT
Organization address
address: Stevinweg 1 contact info |
NL (DELFT) | participant | 0.00 |
| 17 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 0.00 |
| 18 |
UNIVERSITY OF LEICESTER
Organization address
address: University Road contact info |
UK (LEICESTER) | participant | 0.00 |
| 19 |
UNIVERSITY OF SOUTHAMPTON
Organization address
address: Highfield contact info |
UK (SOUTHAMPTON) | participant | 0.00 |
| 20 |
UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
SE (UPPSALA) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The REvolutionary Approaches and Devices for Nucleic Acid analysis – READNA – consortium is composed of researchers from 10 academic institutions, 5 SMEs and 3 large companies. The goals of the READNA consortium are to revolutionize nucleic acid analysis methods, by 1) improving elements necessary to use the currently emerging generation of nucleic acid sequencers in a meaningful and accessible way, 2) providing methods that allow in situ nucleic acid analysis and methods capable of selectively characterizing mutant DNA in a high background of wildtype DNA, 3) combining RNA and DNA analysis in a single analytical device, 4) providing technology to efficiently analyze DNA methylation (genome-wide, with high resolution and in its long-range context), 5) implementing novel concepts for high-throughput HLA-screening, 6) developing fully integrated solutions for mutational screening of small target regions (such as for screening newborns for cystic fibrosis mutations), 7) developing a device for screening multiple target regions with high accuracy, and 8) implementing strategies for effective and high-resolution genotyping of copy number variations. An important part of READNA is dedicated to the development of the next generation of nucleic analysis devices on individual DNA molecules by stretching out nucleic acid molecules in nanosystems, using alpha-hemolysing nanopores and carbon nanotubes. These approaches will benefit from improved interrogation and detection strategies which we will develop. Our methods and devices will boost the possibilities of genetic research by closing in on the target of 1000 Euros for the sequence of a complete human genome, while at the same time leading a revolution in cost-effective, non-invasive early screening for diseases such as cancer.'
Introduzione (Teaser)
The EU-funded READNA project will develop a toolbox of nucleic acid analysis methods. Applications include predicting risk of cancer and personalised medicine.